The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression

Completed · Phase 2

Conditions studied: Treatment Resistant Depression

In brief

The Safety and Efficacy of Psilocybin in Participants with Treatment Resistant Depression

Key facts

Study ID

NCT03775200

Run by

COMPASS Pathways

People needed

233

Starts

2019-03-01

Expected to finish

2021-09-27

Last updated by the study team

2023-04-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of TRD

You may not qualify if…

• Other comorbidities

Where it is running

• Kadima Neuropsychiatry Institute — La Jolla, California, United States
• Altman Clinical and Translational Research Institute, University of California — San Diego, California, United States
• Stanford Department of Psychiatry — Stanford, California, United States
• Mood and Anxiety Disorders Program Emory University School of Medicine — Atlanta, Georgia, United States
• Ray Worthy Psychiatry LLC — New Orleans, Louisiana, United States
• Sheppard Pratt Health System — Baltimore, Maryland, United States
• New York State Psychiatric Institute — New York, New York, United States
• UT Center of Excellence on Mood Disorders, University of Texas Health Science Center — Houston, Texas, United States
• Canadian Rapid Treatment Centre of Excellence — Mississauga, Ontario, Canada
• Centre for Addiction and Mental Health — Toronto, Ontario, Canada
• National Institute of Mental Health Czech Republic — Klecany, Czechia
• Enhed for Psykiatrisk Forskning, Psykiatrien i Aalborg — Aalborg, Denmark
• Charité - Universitätsmedizin Berlin, Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin — Berlin, Germany
• Tallaght University Hospital — Dublin, Ireland
• Groningen University Medical Centre — Groningen, Netherlands
• Leiden University Medical Centre — Leiden, Netherlands
• Utrecht University Medical Centre — Utrecht, Netherlands
• Unidade de Neuropsiquiatria, Centro Clinico Champalimaud — Lisbon, Portugal
• Hospital de Dia Numancia — Barcelona, Spain
• Institute Hospital del Mar of Medical Research (IMIM) — Barcelona, Spain
• Clinical Research and Imaging Centre — Bristol, Avon, United Kingdom
• Wolfson Research Centre, Campus for Ageing and Vitality — Newcastle upon Tyne, Tyne and Wear, United Kingdom
• St. Pancras Clinical Research — London, United Kingdom
• Kings College London, Institute of Psychiatry, Psychology and Neurology — London, United Kingdom
• Greater Manchester Mental Health Foundation Trust — Manchester, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.